Trilla’s responsibilities include supporting international development of the Company’s product candidates by identifying markets, governments, and partners interested in Veru’s portfolio, negotiating applicable agreements, and providing alliance management.ĭr. Sergi Trilla, M.D., M.B.A., is the Chief Business Officer at Veru. in Basic Pharmaceutical Sciences (Clinical Pharmacology and Pharmacokinetics) from West Virginia University, School of Pharmacy. FDA, where he received numerous awards for reviewing, mentoring, and serving on various FDA guidance development groups and initiative task forces. Barnette was a Clinical Pharmacology and Biopharmaceutics Reviewer at the U.S. Barnette managed responsibilities across regulatory, clinical, clinical pharmacology, and medical affairs departments for urology (men’s health) and cancer supportive care. Barnette served in various positions at GTx, Inc., including as Vice President, Clinical Development Strategy. Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services, LLC, during which he oversaw the development of scientific and regulatory drug development strategies across all therapeutic areas for 6 years. On July 31, 2017, we changed our corporate name from “The Female Health Company” to “Veru Inc.,” reflecting our focus on developing and commercializing biopharmaceutical products for infectious disease and oncology. And Urev, our Sexual Health Program, focuses on pressing needs in women’s sexual and reproductive health. Later, we redirected the clinical development of our drug candidate, sabizabulin, a dual antiviral and anti-inflammatory agent, for SARS-CoV-2 ARDS and other viral ARDS related infectious diseases. On October 31, 2016, we completed the acquisition of Aspen Park Pharmaceuticals, Inc., which transitioned us from a single product company into a biopharmaceutical company with a focus on developing novel medicines for oncology. In 1996, we completed the acquisition of worldwide rights to our first-generation female condom, the divestiture of Wisconsin Pharmacal’s other businesses, and the change of our name to “The Female Health Company.”
Wisconsin Pharmacal was originally incorporated in 1971.
(Wisconsin Pharmacal), a company which manufactured and marketed disparate specialty chemical and branded consumer products. Veru is a Wisconsin corporation and is the successor to The Wisconsin Pharmacal Company, Inc.
0 kommentar(er)
